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Boosting the sensitivity of in vitro β-lactam allergy diagnostic tests 
Edurne Peña-Mendizabala, Sergi Morais*,a,b,c and Ángel Maquieiraa,b,c
The synthesis of structurally new haptens and development of 
suitable antigens is essential for boosting the sensitivity of drug 
allergy diagnostic testing. Unprecedented structural antigens for 
benzylpenicillin and amoxicillin are characterised and evaluated in 
a cohort of 70 subjects with a turnkey solution based on consumer 
electronics. 
β-lactams (BLCs) are the most extensively used antibiotics 
for the treatment of bacterial infections1,  but also the most 
frequently involved in allergic reactions.2,3 Penicillins -BLC 
antibiotics- represent 37% of total antibiotic consumption in the 
European Union. Between 2016 and 2018 the median intake 
was 7.1 defined daily doses per 1,000 inhabitants per day. 4 
According to the hapten hypothesis on the mechanism of 
antigen presentation, a drug (e.g., a hapten) covalently binds to 
specific lysine residues of endogenous proteins (carrier 
molecule) to be processed and presented by cells, eliciting an 
immune response5. The mechanism involves the production of 
major (–oyl) and minor (–anyl) antigens.6,7 Approximately 95% 
of penicillin molecules results in the penicilloyl configuration, 
involved in 75 % of IgE-mediated allergic reactions. 8,9 
Quantitative inhibition methods have allowed to establish a 
correlation between fine structural features of haptens and 
allergic sensitivities in patients.10,11 For effective development 
of sensitive and selective in vitro tests, the chemical structure 
of the hapten, among other critical variables, is essential to 
define the specific epitope that binds to the carrier molecule. 
Spacer arms have been widely used in the haptenization of 
small molecules 12–14 to increase exposure of the epitope and 
also to covalently link the hapten to a carrier molecule, reducing 
steric hindrances.15 Experimental data on drug-derived antigens 
is limited. Montañez et al. synthetized different cephalosporin 
skeletons conjugated to carrier molecules to establish 
structure-IgE molecular recognition relationships16, while 
Pastor-Navarro et al. synthetized various haptens for 
tetracyclines using spacer arms to induce heterology in their 
chemical structures.17 Some results suggest that the 
conformational epitope should be accessible to generate 
antigens that are better recognized by specific IgEs.18,19 
According to certain researchers the ideal spacer arm should 
have14: (I) a proper length (at least three atoms), (II) no active 
centre that could lead to non-specific adsorption, and (III) 
bifunctional groups to react with the hapten and the carrier 
molecule. Another strategy to enhance drug-IgE molecular 
recognition is to prepare effective antigens with higher 
hapten:carrier ratio to increase the strength and specificity of 
the immune response and subsequent antibody generation.20 
This may be achieved by forming additional amines on the 
carrier protein by using cross-linkers to convert negatively 
charged carboxylates to positively charged amines.21 Cationized 
proteins are known to increase the immune response compared 
to their native forms making them possible promising molecules 
to boost molecular recognition events.22  
In this work, a collection of 13 diamine-derived haptens for 
benzylpenicillin (PG) and amoxicillin (AMX) was synthesized 
with aliphatic diamines of different alkyl chain lengths. To this 
end, the spacer arm was placed (1) at the carbonyl carbon after 
β-lactam ring opening (–oyl) and (2) at the carboxylic acid of the 
thiazolidine ring (–anyl), maintaining the β-lactam ring common 
to all BLCs, maximizing exposure to the lateral chain. Of the 13 
haptens (see Supplementary nuclear magnetic resonance 
spectra), six were –oyl (1-6, Scheme S1) and seven -anyl (7-13) 
haptens, using PG (haptens 1-3 and 7-9) and AMX (haptens 4-6 
and 10-13) as the starting material. These haptens were used to 
develop antigens (Scheme 1) conjugated to human serum 
albumin (HSA) prepared following the carbodiimide chemistry. 
HSA was employed due to its content of glutamic and aspartic 
residues, 60 and 30, respectively. Next, five antigens, one for 
HSA and four for histone H1, were prepared using cationized 
carrier proteins (Scheme 2). The effect of diamine chain length 
on molecular recognition of the diamine-based antigens was 
assessed by a multiplex microimmunoassay developed on a 
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DVD with colorimetric detection (Figure S1-S2), using a hacked 
disc drive as detector.23 
Scheme 1. Reaction pathway for antigen preparation 
a) Protein, Na2CO3, pH=11, rt; b) 0.1 M DCM/DMF, then protein, 1x PBS
pH=7,4, rt. PG, benzylpenicillin AMX, amoxicillin 
Using the results of a reference antigen 14, three comparisons 
were made. First, polyclonal IgGs to PG were used. These 
specific IgGs were obtained after rabbit immunization with the 
reference –lloyl antigen linked to keyhole limpet haemocyanin 
(Scheme S3). Sera dilutions ranging from 1/1,000 to 1/32,000 
were tested and PBS-T was used as blank control. Results are 
plotted in Figure 1. No recognition was observed for either HSA 
(< 500 arbitrary units) or the antigen prepared with aztreonam 
(AZT) (<700 arbitrary units), used as negative controls. The term 
molar recognition ratio (MRR) was used to compare antigenic-
specific responses, representing the ratio between the signal 
given by the –oyl and/or –anyl antigen(s) to the reference signal 
(antigen 14) and expressed as percentages. Overall, all 
synthesized antigens detected polyclonal IgG to PG and the 
assay signals were similar to those obtained for the reference 
antigen. For -oyl antigens (Figure 1a), PG-based antigens 1-3 
showed higher MRRs (ca. 103-123 %), while for AMX-based 
antigens 4-6, MRRs ranged between 86 and 102 %.  
Scheme 2. Chemical structures of the antigens using diamine cationized 
proteins.  
[a] Reaction conditions: -oyl haptens: 0.5 M sodium carbonate, pH 11.0 
Furthermore, the results revealed that –oyl antigens linked to 
1,5-diaminopentane had the best responses, with MRR values 
of 123% and 102% for PG and AMX-based antigens, 
respectively. On the other hand, 1,7-diaminoheptane-based 
antigens had the lowest MRR values. For antigen 1b, where 
cationized carrier molecules were used, results were similar, 
with a MRR of 95%. Signals of –anyl antigens (Figure 1b) were 
lower than for the reference. PG and AMX-based antigens 7-9 
and 10-13 had MRRs between 76% and 98% and 58% and 88%, 
respectively. On the protective effect of the free amine on AMX, 
antigen 13 achieved higher MRR values (ca. 86%) than its 
corresponding non-protected antigen 10, with a MRR value of 
58%. Contrarily, no general agreement was reached regarding 
diamine alkyl chain length. Indeed, antigen 10, linked to 1,3-
diaminopropane showed the lowest serum response (ca. 58 %) 
for AMX, while PG antigen 9, linked to 1,7-diaminopentane, 
reached higher MRR value (76%). In short, recognition of PG-
modified antigens was better than for AMX.  
Figure 2 shows the results of the evaluation of artificial 
human serum to PG. Variations were observed in PG-based 
antigens depending on the conjugation strategy. Antigens 1b 
and 2b, in which diamines where used to cationize the carrier, 
reached specific IgE (sIgE) concentrations of 23 IU/mL, ten times 
higher than the reference, indicating good recognition of the 
sera for these antigens. Regarding AMX-antigens, the best 
results were seen for antigens 5 and 6 with sIgE concentrations 
of 20 IU/mL. 
Figure 1. Signals (in arbitrary units, a.u.) for the modified β-lactams antigens with specific rabbit IgG to benzylpenicillin (n=5; dilution factors 
represented: 1/1,000, 1/4,000 and 1/16,000). a) –oyl antigens and b) –anyl antigens.
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Figure 2. Evaluation of β-lactam antigens with artificial human serum 
specific to benzylpenicillin ([IgE] = 25 IU/mL). [a] 1 IU/mL = 2.4 ng/mL. 
The sensitivity measured as 50% effective concentration (EC50) was 2.08 
± 0.78 IU/mL and the limit of detection, calculated as the concentration 
corresponding to the signal of the blank plus three times its standard 
deviation, was 0.07 IU/mL. The inset shows the standard curve for total 
IgE. The limit of quantification was 0.92 IU/mL and the relative standard 
deviation ranged from 3 to 15%. *indicates a statistically significant 
difference (p<0.001) as compared to reference antigen 14. ** indicates 
concentrations were below the limit of quantification. 
No improvement of the results was seen when the free 
amine group of AMX was protected, as observed for antigens 7 
and 13, with sensitivities of 5 and 1 IU/mL, respectively. This 
may explain why antigens 5 and 6 were promising for in vitro 
diagnosis of BLC allergy. The conjugation of AMX could have 
been directed not only towards the free amine of the diamine, 
but also towards the free amine in its lateral chain, improving 
the molecular recognition yield. It may also explain the better 
response for AMX antigens, prepared by using diamines as 
spacer arms for the hapten synthesis in comparison to PG-based 
antigens, even in PG-specific artificial human serum. 
Furthermore, spacer arm length showed different patterns 
regarding the BLC antigen selected. This is in line with the 
results of previous study in which molecular recognition 
differed on the selected hapten.24 
A cohort of 70 subjects, 35 of which developed an 
immediate reaction to β-lactams (Table S1), was tested. Prick 
tests (in vivo), ImmunoCAP, and the multiplex immunoassay (in 
vitro) results are shown in Table S2. When diamines were used 
as spacer arms (both –oyl and –anyl antigens) results were 
negative, with values below the limit of detection. Prick tests 
showed that four out of 31 PG patients (13 %) and 21 out of 31 
AMX patients (68 %) were positive. With the in vitro 
ImmunoCAP reference test from the 35 allergic patients, seven 
PG (20 %) and thirteen AMX (37 %) were positive. The in vitro 
ImmunoCAP test allows sIgE to be quantified within a range of 
0.01 to 100 IU/mL, with a cut-off point of 0.35 for positive 
results and levels above 0.10 IU/mL indicating sensitization. 
Furthermore, recent data indicates that the specificity of the 
immunoCAP system ranges from 85.7% to 100%, while 
sensitivity ranges from 0% to 25%, depending on initial clinical 
symptoms.25 The evaluation of our antigens with the multiplex 
DVD-microimmunoassay in a cohort of 35 allergic patients, 
resulted in 21 PG (60 %) and 11 AMX (31 %) subjects positive 
with antigen 3b. The 35 control patients were negative. Figure 
3 shows a dot plot diagram of the clinical performances of the 
developed multiplex microimmunoassay.  
Evaluation of the different diamines used to modify the 
carrier proteins with AMX (antigens 3b, 4b and 5b) revealed 
that the shorter diamine, ethylene diamine, provided the best 
results. Its short chain length ensures minimal steric effects and 
virtually no hydrophobic interactions while the aromatic ring 
presented in 1,4-phenylenediamine may induce extremely 
steric effects and become less accessible. For instance, patient 
04 had a specific IgE value to AMX of 0.44 IU/mL when ethylene 
diamine was used, and 0.02 IU/mL when both 1,4-
diaminobutane and 1,4-phenylenediamine were used. The 
same was observed with patient 09 with values of 2.75, 0.04, 
and 0.06 IU/mL, respectively.  
Figure 3. Dot plot of the specific IgE levels to PG and AMX determined 
by the multiplex DVD-assay. Positive and negative refer to samples from 
allergic patients and control subjects, respectively. The cut-off 
considered is the limit of detection of the developed multiplex DVD-
assay and is represented as a blue line (>0.07). Sens and Spec stand for 
sensitivity and specificity using antigens 1b and 3b for PG and AMX, 
respectively.  
In conclusion, the search for new antigens for allergy testing 
involves synthesis and screening of chemical entities to 
delineate the selectivity and the strength of interaction 
between the antigens and the IgE targets. Given the need to 
consider side-chain on individual β-lactam derived antigens and 
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the heterogeneity of the target β-lactam antibiotics, this 
research contributes with new approaches to synthesize 
structural haptens and generating specific antigens for 
immunoanalytical determination of IgEs, going beyond the state 
of the art. As we demonstrate, the synthesis of structurally new 
haptens to generate antigens for β-lactam allergy is key for 
developing highly sensitive in vitro tests to determine specific 
IgG and IgE antibodies. The purpose of our study was to 
synthetize a collection of haptens to produce a panel of major 
and minor antigens for PG and AMX to determine sIgE for these 
BLCs. We obtained a panel of 18 antigens, as well as a collection 
of different haptens (epitopes) using diamines of various length 
and different linkage strategies. To the best of our knowledge, 
this is the first report that describes the development of 
modified major and minor –oyl and –anyl antigens for 
benzylpenicillin and amoxicillin, demonstrating the potential for 
an improved serological diagnosis of IgE-mediated drug allergic 
reactions for commonly prescribed and consumed β-lactam 
antibiotics. We henceforth determine the presence of IgE 
antibodies in a defined allergic population in which Augmentin 
and amoxicillin were the most common inducers of immediate 
reactions. The results with patients showed that antigens for 
which diamines were used as spacer arms were not detected, 
although they recognized both specific IgG and IgE from 
immunized rabbits and artificial human sera to PG. We found a 
good correlation between our multiplex DVD immunoassay and 
ImmunoCAP for positive samples to both PG and AMX. 
Cationization of carrier molecules with diamines and their 
subsequent use to generate antigens is a suitable approach to 
detect specific IgE at low concentrations in allergic patients, 
improving the sensitivity of the existing in vitro tests for drug 
allergy. This result reveals that cationized antigens are a 
promising alternative to current –oyl derived antigens for 
boosting the sensitivity of the current in vitro test in antibiotic 
allergy. Synthesized amoxicillin –oyl haptens enhance drug-IgE 
molecular recognition, increasing three-fold the sensitivity of 
the existing in vitro diagnostic testing for antibiotic allergy. The 
current lack of clinically standardized reagents make the panel 
of synthesized structural haptens and the generated specific 
antigens a promising approach for massive detection of 
antibiotic allergies. In this way, better drug sensitization profiles 
could be defined, which will be of valuable support for allergy 
screening campaigns and antibiotic delabeling process. 
This work has been funded by the H2020 program (project 
COBIOPHAD, grant agreement No. 688448), being an initiative 
of the Photonics Public Private Partnership; Agencia Estatal de 
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